Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B E Bleske

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Pharmacotherapy|November 23, 2000
Evolution and pathophysiology of chronic systolic heart failureB E Bleske
Connecticut Medicine|October 1, 1987
EsmololB E Bleske
Clinical Pharmacy|May 1, 1990
Current concepts of silent myocardial ischemiaB E Bleske, M J Shea
JAMA|June 27, 1986
Converting patients from intravenous lidocaine to oral tocainide treatmentG G Zhanel, B E Bleske
Resuscitation|December 1, 1994
Comparison of adrenergic agonists for the treatment of ventricular fibrillation and pulseless electrical activityB E Bleske, J E Billi
Journal of Clinical Pharmacy and Therapeutics|June 14, 2014
Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agentsC P Walter, B E Bleske, M P Dorsch
Pharmacotherapy|January 1, 1994
An alternative sodium bicarbonate regimen during cardiac arrest and cardiopulmonary resuscitation in a canine modelB E Bleske, T L Rice, E W Warren
Therapeutic Drug Monitoring|January 1, 1987
Observed differences in amikacin pharmacokinetic parameters and dosage recommendations determined by enzyme immunoassay and fluorescence polarization immunoassayB E Bleske, T A Larson, J C Rotschafer
Pharmacotherapy|August 6, 1998
Carvedilol: therapeutic application and practice guidelinesB E Bleske, E M Gilbert, M A Munger
Journal of Clinical Pharmacology|November 1, 1989
Acute effects of combination of IB and IC antiarrhythmics for the treatment of ventricular tachycardiaB E Bleske, J Kluger, J Fisher, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Pharmacotherapy|November 23, 2000
Evolution and pathophysiology of chronic systolic heart failureB E Bleske
Connecticut Medicine|October 1, 1987
EsmololB E Bleske
Clinical Pharmacy|May 1, 1990
Current concepts of silent myocardial ischemiaB E Bleske, M J Shea
JAMA|June 27, 1986
Converting patients from intravenous lidocaine to oral tocainide treatmentG G Zhanel, B E Bleske
Resuscitation|December 1, 1994
Comparison of adrenergic agonists for the treatment of ventricular fibrillation and pulseless electrical activityB E Bleske, J E Billi
Journal of Clinical Pharmacy and Therapeutics|June 14, 2014
Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agentsC P Walter, B E Bleske, M P Dorsch
Pharmacotherapy|January 1, 1994
An alternative sodium bicarbonate regimen during cardiac arrest and cardiopulmonary resuscitation in a canine modelB E Bleske, T L Rice, E W Warren
Therapeutic Drug Monitoring|January 1, 1987
Observed differences in amikacin pharmacokinetic parameters and dosage recommendations determined by enzyme immunoassay and fluorescence polarization immunoassayB E Bleske, T A Larson, J C Rotschafer
Pharmacotherapy|August 6, 1998
Carvedilol: therapeutic application and practice guidelinesB E Bleske, E M Gilbert, M A Munger
Journal of Clinical Pharmacology|November 1, 1989
Acute effects of combination of IB and IC antiarrhythmics for the treatment of ventricular tachycardiaB E Bleske, J Kluger, J Fisher, et al.
Pageof 3